{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-23-000056","form_type":"8-K","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2023-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.167326+00:00","generated_at":"2026-06-09T09:23:08.767378+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Merit Medical Q3 revenue $315.2M (+9.8% YoY); GAAP EPS $0.44, adjusted $0.75; guides up","bullets":["Q3 revenue $315.2M, up 9.8% YoY; constant currency revenue up 9.7%, organic constant currency up 7.1%.","GAAP operating margin 11.1% vs 6.5% in Q3 2022; non-GAAP operating margin 18.3% vs 16.1%.","GAAP EPS $0.44 (up from $0.27); non-GAAP EPS $0.75 (up from $0.64).","Company raises fiscal year 2023 financial guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-23-000056","json":"https://secwatch.observer/filing/0000856982-23-000056.json","markdown":"https://secwatch.observer/filing/0000856982-23-000056.md","text":"https://secwatch.observer/filing/0000856982-23-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000056/0000856982-23-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000056/mmsi-20231026x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T09:23:08.767378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba8791aeba65b56d93c2b7a72384d4919a27d303","claim":"MERIT MEDICAL SYSTEMS INC reported for the quarter ended September 30, 2023 results: revenue $315.2 million, EPS $0.44. Guidance raised.","evidence_excerpt":"mike.piccinino@westwicke.com ​ ​ ​ ​ ​ ​ ​ ​ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS RESULTS FOR THIRD QUARTER ENDED SEPTEMBER 30, 2023 ​ ● Q3 2023 reported revenue of $315.2 million, up 9.8% year-over-year ● Q3 2023 constant currency revenue* up 9.7% year over year ● Q3 2023 constant currency revenue, organic* up 7.1% year-over-year ● Q3 2023 GAAP operating","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000056/0000856982-23-000056-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for the quarter ended September 30, 2023"},{"label":"Revenue","value":"$315.2 million"},{"label":"EPS","value":"$0.44"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}